Enabling Precision Medicine

Nathan Fowler, MD
Chief Medical Officer

About

From Treating a Diagnosis to Treating the Patient

BostonGene’s mission is to power healthcare’s transition to personalized medicine using AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics.

The BostonGene Tumor Portrait™ test integrates genomic (WES) and transcriptomic (RNA-seq) analyses of tumors and the tumor microenvironment in the single report to reveal key drivers of each tumor, including:

  • Immune microenvironment properties
  • Actionable mutations
  • Biomarkers of response to diverse therapies
  • Therapy options

After a comprehensive analysis, the BostonGene Tumor Portrait™ test generates a personalized roadmap for therapeutic decision-making for individual cancer patients.

Partners
Publications
News
Events

Learn more from the experts and professionals at premier industry events with BostonGene to better understand the technology of today and tomorrow.
Careers

Are you someone who wants to move the pace in which precision medicine is able to assist doctors in finding the most effective strategy for precision cancer therapy? Then do we have a job for you!

Questions
Contact us